Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
Status:
Completed
Trial end date:
2018-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether UTD1 Injection in combination with
capecitabine is effective in the treatment of advanced metastatic breast cancer using
capecitabine as a control.